MedTrace Logo

The Impact of RPh201 on CVS Patients: Clinical and fMRI Measurements

NCT01417299 · Status: WITHDRAWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2015-09-22

No results posted yet for this study

Summary

The investigators are studying the impact of RPh201 on chronic vegetative patients. RPh201 has been reported to induce neuronal regeneration in animal models. Evaluation will be done by combining clinical /behavioral assessment with fMRI studies.

Conditions

  • Chronic Vegetative State

Interventions

DIETARY_SUPPLEMENT

RPh201

Patients will receive 400 microliter s.c., of RPh201 twice a week for 3 months

DIETARY_SUPPLEMENT

saline

Patients will receive 400 microliter s.c., of saline twice a week for 3 months

Sponsors & Collaborators

  • Hadassah Medical Organization

    lead OTHER

Principal Investigators

  • Tamir Ben-Hur, MD PhD · Hadassah Medical Organization

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2017-10-31
Completion
2018-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01417299 on ClinicalTrials.gov